Opdivo Trademark Details

Opdivo was registered on Tuesday, March 8, 2016 and is currently owned by Bristol-Myers Squibb Company under the registration number 4914296 . This mark is alive with a status of Registered. The last case file activity for this mark occured 7 years ago on Tuesday, March 8, 2016, according to the United State Patent & Trademark Office
Word Mark Opdivo
Status Alive Registered 700 — Registered

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 86174642
Registration Number 4914296
Status Date Tuesday, March 8, 2016
Filing Date Tuesday, March 8, 2016
Registration Date Tuesday, March 8, 2016
Attorney Marilyn F. Kelly

Correspondent

MARILYN F. KELLY
BRISTOL-MYERS SQUIBB COMPANY
PO BOX 4000
PRINCETON, NJ 08543-4000

Case File Statements

Amendment to a Registration/Renewal Certificate In the statement, Line 4, through line 11, "Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies" is deleted, and Pharmaceutical preparations for human use for the treatment and prevention of cancer is inserted.
Indication of Colors Color is not claimed as a feature of the mark.
Description of Mark The mark consists of the word "OPDIVO" in stylized font with a diagonal double slash design appearing below the first "O" and above the "V".
Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of [ obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, ] cancer [, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies ]

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, February 5, 2014
First Use Anywhere Monday, July 6, 2015
First Use In Commerce Monday, July 6, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.